Latest Operational Performance News

Acrow Limited has secured $70 million through a fully underwritten two-tranche placement to acquire Ausgroup Industrial Services and Preston SuperDeck, boosting its FY27 revenue and EBITDA guidance significantly.

Emeco Holdings expects FY26 operating EBITDA near $290 million despite weather and supply headwinds, while FY27 outlook targets stable earnings with improved utilisation and ongoing deleveraging.

Great Divide Mining Ltd (ASX: GDM) has received its first cash payment of USD 78,480.35 from gold concentrate sales at its Challenger Gold Mine, marking a key milestone in its transition from explorer to producer within three years of listing.

Hillgrove Resources has delivered consistent high-grade copper-gold drill results from its Emily Star underground project, underpinning a pivotal Stage 2 investment decision later this year.

Great Divide Mining Ltd (ASX: GDM) has received its inaugural cash payment from concentrate sales under a 12-month offtake agreement, marking a key step from exploration to production at its Challenger Gold Mine.

Delegat Group has raised its full-year Operating Net Profit after Tax forecast to $60-62 million, up from $50-55 million, driven by stronger global sales, lower US tariffs, and favourable FX.

Meridian Energy secures long-term operational certainty for its flagship Waitaki Power Scheme, maintaining generation capacity and storage with a focus on biodiversity enhancements.

Eureka Group Holdings (ASX: EGH) expects FY26 underlying EBITDA to meet or exceed $21.1 million, driven by seniors’ occupancy above 97% and rent growth exceeding 6%. Capital recycling and a robust acquisition pipeline support growth.

WasteCo Group has inked a $10 million funding deal with PFNZ Limited, enhancing its working capital and financial flexibility to support operational improvements and future expansion.

DigiCo Infrastructure REIT has agreed to sell its LAX1 and LAX2 data centres at cost, aiming to recycle capital into its higher-returning SYD1 development. The sale, expected in the first half of FY27, will lift available liquidity to about $1 billion following the earlier Chicago sale.

Monash IVF lowers its FY26 underlying NPAT guidance to $17-18 million, citing a 4.7% drop in Australian stimulated IVF cycles. Despite this, the company has expanded its national market share to 20.1% and seen international volume growth.

Green Cross Health Limited reported a 28% rise in net profit to NZD 20.4 million for FY26, driven by gains in both pharmacy and medical divisions. The company announced a conditional sale of its Medical division to Tend Health for NZD 270 million, aiming to refocus on its core pharmacy business.